Outsourcers keep small molecules

No, Drug Outsourcing Firms Haven’t Abandoned the Small Molecule

Executives at CPHI reaffirmed that small molecule chemistry remains core for drug outsourcing firms, despite heavy investments in biologics by companies like Lonza and Samsung Biologics. Traditional c